OncoSeer Diagnostics
PrivateLast Round
Seed
Nov 28, 2022
Total Funding Raised
$1M
Company Overview
OncoSeer Diagnostics is a diagnostic equipment company that develops multimarker blood tests to predict, monitor, and diagnose immune-related adverse events in oncology patients undergoing immune checkpoint inhibitor therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoSeer Diagnostics Comparables
Compare OncoSeer Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoHost | 78% | |
| ImmunoSentry | 64% | |
| Strata Oncology | 63% |
OncoSeer Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 28, 2022 | ||||
| Grant | Sep 1, 2020 | ||||
| Grant | Jul 1, 2018 |
OncoSeer Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Melanoma Research Alliance | Grant |
| National Institutes of Health (NIH) | Grant |
| JMS Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Monthly visitors increased 34% MoM.
- Jul 3, 2025
Monthly visitors increased 1838% MoM, reaching 872.
OncoSeer Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OncoSeer Diagnostics's valuation, stock price, and market status.
Is OncoSeer Diagnostics a public or private company?
OncoSeer Diagnostics is a private company.
What is the current stock price of OncoSeer Diagnostics?
OncoSeer Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is OncoSeer Diagnostics worth (valuation)?
Valuation information for OncoSeer Diagnostics is not publicly available.
Can I buy OncoSeer Diagnostics stock?
OncoSeer Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OncoSeer Diagnostics's last funding round?
OncoSeer Diagnostics's most recent funding round was Seed on November 28, 2022.
Who are the main investors in OncoSeer Diagnostics?
Key investors in OncoSeer Diagnostics include National Institute of Allergy and Infectious Diseases, Melanoma Research Alliance, National Institutes of Health (NIH), JMS Capital.
Will OncoSeer Diagnostics IPO soon?
No public IPO plans have been announced for OncoSeer Diagnostics.
How can I track OncoSeer Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoSeer Diagnostics's secondary market activity and sign up for updates.